Curis Inc - Company Profile
Powered by 
All the sales intelligence you need on Curis Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Curis Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Curis Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Curis Clinical Trials
Determine Curis Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Curis Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| Treatment of Anemia in Patients with Very Low, Low or Intermediate Risk Myelodysplastic Syndromes with CA-4948 (LUCAS) | GDCT0412022 | emavusertib hydrochloride | Hematological Disorders; Oncology | Anemia; Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia); Chronic Myelomonocytic Leukemia (CMML); Myelodysplastic Syndrome | Phase II | Ongoing, recruiting | University of Leipzig |
| Phase I Study of CI-8993 Anti-VISTA Antibody in Patients with Advanced Solid Tumor Malignancies | GDCT0376637 | onvatilimab | Oncology | Advanced Malignancy; Bladder Carcinoma; Cervical Cancer; Colorectal Cancer; Head And Neck Cancer; Malignant Mesothelioma; Melanoma; Non-Small Cell Lung Cancer; Pancreatic Cancer; Small-Cell Lung Cancer; Solid Tumor; Triple-Negative Breast Cancer (TNBC) | Phase I | Ongoing, recruiting | Curis Inc |
| Dose Escalation/ Expansion Trial of CA-4948 as Monotherapy and in Combination With Azacitidine or Venetoclax in Patients With AML or MDS | GDCT0373395 | emavusertib hydrochloride | Oncology | Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia); Myelodysplastic Syndrome; Non-Hodgkin Lymphoma; Primary CNS Lymphoma; Refractory Acute Myeloid Leukemia; Relapsed Acute Myeloid Leukemia | Phase I/II | Ongoing, not recruiting | Curis Inc |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer